XERS
Xeris Biopharma·NASDAQ
--
--(--)
--
--(--)
3.55 / 10
Netural
Technical analysis scores 3.55/10, indicating a challenging structure. Dominant bearish signals include the MACD Death Cross and Long Lower Shadow, outweighing the moderate Long Upper Shadow impulse. Recent candlestick patterns show volatility with no clear trend, leading to a cautious stance until a decisive breakout or breakdown occurs.
Analysis Checks(1/4)
Long Lower Shadow
Score1.35/10
Win Rate40.00%
Hist. Signals15
Avg Return-1.30%
Score1.35/10
Win Rate40.00%
Hist. Signals15
Avg Return-1.30%
MACD Death Cross
Score2.9/10
Win Rate44.44%
Hist. Signals9
Avg Return0.06%
Score2.9/10
Win Rate44.44%
Hist. Signals9
Avg Return0.06%
Long Upper Shadow
Score6/10
Win Rate53.85%
Hist. Signals26
Avg Return1.11%
Score6/10
Win Rate53.85%
Hist. Signals26
Avg Return1.11%
Bullish Engulfing
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.18%
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.18%
Long Lower Shadow
Score1.35/10
Win Rate40.00%
Hist. Signals15
Avg Return-1.30%
Score1.35/10
Win Rate40.00%
Hist. Signals15
Avg Return-1.30%
Long Upper Shadow
Score6/10
Win Rate53.85%
Hist. Signals26
Avg Return1.11%
Score6/10
Win Rate53.85%
Hist. Signals26
Avg Return1.11%
MACD Death Cross
Score2.9/10
Win Rate44.44%
Hist. Signals9
Avg Return0.06%
Score2.9/10
Win Rate44.44%
Hist. Signals9
Avg Return0.06%
Bullish Engulfing
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.18%
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.18%
What is the current technical signals for XERS?
- XERS presents a Netural setup with a Technical Score of 3.55/10. Key technical indicators highlight an RSI of 41.38 and a MACD of -0.13, with the trend anchored by the 50-Day SMA at 7.25. Traders should monitor key support at 6.76 and resistance at 7.13.
